| Report of the Lancet Commission on the Value of Death: bringing death back into life L Sallnow, R Smith, SH Ahmedzai, A Bhadelia, C Chamberlain, Y Cong, ... The Lancet, 2022 | 308 | 2022 |
| Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource A Wood, R Denholm, S Hollings, J Cooper, S Ip, V Walker, S Denaxas, ... BMJ 373, 2021 | 128 | 2021 |
| Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist F Xie, K Gaebel, K Perampaladas, B Doble, E Pullenayegum Medical Decision Making 34, 8-20, 2014 | 105 | 2014 |
| Utility of incorporating next generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: incremental yield of actionable alterations and cost … AC Tan, GGY Lai, G San Tan, SY Poon, B Doble, TH Lim, ZW Aung, ... Lung Cancer 139, 207-215, 2020 | 100 | 2020 |
| A randomized controlled trial evaluating the relative effectiveness of the multiple traffic light and nutri-score front of package nutrition labels E Finkelstein, FJL Ang, B Doble, WHM Wong, R van Dam Nutrients 11 (9), 2236, 2019 | 86 | 2019 |
| Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic … B Doble, G Blackhouse, R Goeree, F Xie Journal of Thoracic and Cardiovascular Surgery 146 (1), 52-60. e3, 2013 | 78 | 2013 |
| What are the real procedural costs of bariatric surgery? A systematic literature review of published cost analyses B Doble, S Wordsworth, CA Rogers, R Welbourne, J Byrne, JM Blazeby, ... Obesity Surgery 27 (8), 2179–2192, 2017 | 67 | 2017 |
| Prophylaxis of radiation-induced nausea and vomiting using 5-hydroxytryptamine-3 serotonin receptor antagonists: a systematic review of randomized trials N Salvo, B Doble, L Khan, G Amirthevasar, K Dennis, M Pasetka, ... International Journal of Radiation Oncology* Biology* Physics 82 (1), 408-417, 2012 | 61 | 2012 |
| Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L. P Lorgelly, B Doble, D Rowen, J Brazier Quality of Life Research 26 (5), 1163-1176, 2017 | 43 | 2017 |
| Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: an early decision analytic model of multiplex targeted sequencing B Doble, T John, D Thomas, A Fellowes, S Fox, P Lorgelly Lung Cancer 107, 22-35, 2017 | 40 | 2017 |
| Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms B Doble, P Lorgelly Quality of Life Research 25 (4), 891-911, 2016 | 39 | 2016 |
| Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence update S Sehatzadeh, B Doble, F Xie, G Blackhouse, K Campbell, K Kaulback, ... Ontario Health Technology Assessment Series 13 (1), 1-40, 2013 | 38 | 2013 |
| Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist B Doble, M Tan, A Harris, P Lorgelly Expert Review of Molecular Diagnostics 15 (2), 235-254, 2015 | 37 | 2015 |
| Transcatheter aortic valve implantation (TAVI) for treatment of aortic valve stenosis: an evidence-based analysis (Part B). S Sehatzadeh, B Doble, F Xie, G Blackhouse, K Kaulback, K Chandra, ... Ontario Health Technology Assessment Series 12 (14), 1-62, 2012 | 36 | 2012 |
| The promise of personalised medicine. B Doble, D Schofield, T Roscioli, J Mattick Lancet 387 (10017), 433-434, 2016 | 28 | 2016 |
| Prioritizing the application of genomic medicine B Doble, D Schofield, T Roscioli, J Mattick npj Genomic Medicine 2 (35), 2017 | 26 | 2017 |
| Using 'big data' in the cost-effectiveness analysis of next generation sequencing technologies: challenges and potential solutions S Wordsworth, B Doble, K Payne, J Buchanan, DA Marshall, C McCabe, ... Value in Health 21 (9), 1048-1053, 2018 | 25 | 2018 |
| Comment on: systematic assessment of decision analytic models for the cost effectiveness of bariatric surgery for morbid obesity B Doble Surgery for Obesity and Related Diseases 14 (7), 1059-1061, 2018 | 25* | 2018 |
| Budget impact and cost-effectiveness: can we afford precision medicine in oncology? B Doble Scandinavian Journal of Clinical and Laboratory Investigation 76 (sup245 …, 2016 | 21 | 2016 |
| Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study B Doble, M Pufulete, J Harris, T Johnson, D Lasserson, R B, ... Health and Quality of Life Outcomes 16 (191), 2018 | 20 | 2018 |
